Lance Baldo

Chief Medical Officer, Adaptive Biotechnologies.

Companies

Adaptive BiotechnologiesChief Medical Officer Jun 26, 2019 to Mar 10, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Adaptive Biotechnologies ADPT17,171 shares²$412.3K at $24.01Mar 8, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 8, 2022Sold 3,350 shares at $11.43 of Adaptive Biotechnologies²
Mar 7, 2022Sold 2,373 shares at $12.01 of Adaptive Biotechnologies³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAdaptive Biotechnologies, Chief Medical Officer
2
SEC EDGARAdaptive Biotechnologies shares after the filing of Mar 8, 2022
3
SEC EDGARForm 4 filed Mar 8, 2022